We performed the ACE2 assay on EDTA-anticoagulated (obtained using clinical standard lavender top tubes) research participant plasma samples obtained at about day 7 of hospitalization for a cohort of 67 COVID-19 patients with moderate-to-severe disease. This evidence concerns the gene ACE2 and COVID-19.